New COVID-19 Cases Back Above 400 as Authorities Warn of Danger of Variants | Be Korea-savvy

New COVID-19 Cases Back Above 400 as Authorities Warn of Danger of Variants


A temporary coronavirus testing center in Seoul (Yonhap)

A temporary coronavirus testing center in Seoul (Yonhap)

SEOUL, Jan. 23 (Korea Bizwire)South Korea’s daily new COVID-19 cases rose back to above 400 on Saturday, health authorities said.

The country added 431 more COVID-19 cases, including 403 locally transmitted infections, raising the total caseload to 74,692, according to the Korea Disease Control and Prevention Agency (KDCA).

The number of new infections was tallied at 404 on Wednesday and 401 the following day. It then fell to 346 on Friday in the midst of weeks of toughened social distancing restrictions.

Seoul, Gyeonggi Province and Incheon had 119, 113 and 12 cases, respectively, with 33 reported in Busan, 32 in South Gyeongsang Province, 21 in Daegu and 18 in North Gyeongsang Province.

The number of new patients in regions outside the greater Seoul area climbed back to the triple digits.

Among major cases, infections related to an evangelical church facility in Sangju, North Gyeongsang Province, increased to 802 and 18 others were confirmed in connection with a call center in Ansan, Gyeonggi Province, and a family gathering in Suncheon, South Jeolla Province.

Nine additional coronavirus deaths were reported to bring the death toll to 1,337. The fatality rate stood at 1.79 percent.

The authorities conducted a total of 47,484 coronavirus tests Friday, 2,866 more than the previous day, it added.

An accumulated total of 5.33 million COVID-19 tests have been done so far in South Korea, with 136,629 people awaiting results.

An additional 629 patients were released from coronavirus treatment, and 297 others still have serious symptoms, the agency said.

The so-called third wave of the pandemic, which started in November last year and peaked with daily cases of 1,240 on Dec. 25, is showing signs of a let-up.

But many say it’s too early to lower the guard due to infections reported constantly in a number of areas nationwide. The proportion of patients whose infection sources have yet to be traced has been staying above 20 percent.

In this undated file photo, Kwon Joon-wook, deputy director of the Central Disease Control Headquarters, holds a press briefing. (Yonhap)

In this undated file photo, Kwon Joon-wook, deputy director of the Central Disease Control Headquarters, holds a press briefing. (Yonhap)

The government is closely monitoring the trend of infections to decide whether to adjust the social distancing rules now at Level 2.5, the second highest in a five-tier system, in the capital area.

It prohibits private gatherings of five or more people, and puts curbs on business operations after 9 p.m.

Local health authorities, meanwhile, are on high alert over burgeoning variants.

Kwon Joon-wook, deputy director of the Central Disease Control Headquarters, even raised the possibility that the nation will be drawn back into a “nightmare” similar to that of last December.

“Mutant viruses are more contagious than existing ones,” he said during a press briefing later in the day.

While the reproduction rate of the coronavirus here stands at around 0.82, it would jump up to 1.2 if the mutant virus from Britain spreads widely, he added. The rate measures the number of people that the average patient infects.

It represents a very alarming situation, with the British government’s latest announcement signaling the likelihood of a higher fatality rate, Kwon added.

South Korea has confirmed three types of coronavirus variants on its soil, one each from Britain, South Africa and Brazil, with a total of 18 people infected.

The government regards such variants as a major challenge in its already struggling antivirus fight, especially ahead of a full-fledged vaccination program scheduled to start in February.

It said it plans to announce a specific timetable on offering vaccine shots next Thursday.

In a bid to develop the country’s own vaccine, the health authorities are also pushing for technology cooperation with Moderna, an American pharmaceutical and biotechnology company.

The national research center on infectious diseases said it will discuss partnerships on messenger RNA (mRNA) vaccines with Moderna officials via videoconference next Monday.

(Yonhap)

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>